Monopar Therapeutics Inc. (1IY0)
Market Closed
16 Oct, 08:00 PM
XSTU 
€
60. 90
-2.5
-3.9432%
€
- Market Cap
- P/E Ratio
- Div Yield
8 Volume
-0.65 Eps
€ 63.4
Previous Close Want to track 1IY0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monopar Therapeutics Inc. (1IY0) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -28.81
Forward P/E -
PEG ratio -1.37
Price/Sales (ttm) -
Price/Book (mrq) 3.36
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 6.7M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 41.75
52-Week high 105.6
Beta -
50-Day moving average 48.19
200-Day moving average 54.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 13 Aug 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.1%
Return on equity -0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -13.72M
Diluted EPS (ttm) -1.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 56.04%
Book value per share (mrq) 15.86
Cash Flow
Cash flow statement -8.48M
Levered free cash flow (LFCF) -13.72M
2026 © Marketlog. All Rights Reserved.
